Who owns REVANCE THERAPEUTICS INC?
- CUSIP Number: 761330ab5
Tip: Access positions for across all investors
Analyze quarterly positions in Revance Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Revance Therapeutics stock
Who bought or sold REVANCE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| UBS O'Connor | 40M | $38M | 0% | Dec 2024 |
|
| D. E. Shaw & Co | 27M | $26M | 59% | Dec 2024 |
|
| Graham Capital Management | 26M | $25M | -27% | Dec 2024 |
|
| Glazer Capital | 25M | $24M | -8% | Dec 2024 |
|
| Indaba Capital Management | 25M | $24M | 100% | Dec 2024 |
|
| PenderFund Capital Management | 25M | $35M | 16% | Dec 2024 |
|
| CNH Partners | 20M | $19M | 34% | Dec 2024 |
|
| Boothbay Fund Management | 8.5M | $8.1M | 100% | Dec 2024 |
|
| DeepCurrents Investment Group | 4.8M | $4.6M | 90% | Dec 2024 |
|
| Amundi | 3.4M | $3.3M | 0% | Dec 2024 |
|
| BlackRock | 2.8M | $2.7M | 17% | Dec 2024 |
|
| Sonora Investment Management Group | 2.8M | $2.7M | -5% | Dec 2024 |
|
| CSS | 1.5M | $1.4M | -25% | Dec 2024 |
|
| Nuveen Asset Management | 500k | $476k | -99% | Dec 2024 |
|
| American Century Companies | 125k | $120k | 18% | Dec 2024 |
|
| Context Capital Management | 61k | $58M | 15% | Dec 2024 |
|
| Bank of America Corporation | 60k | $57k | 0% | Dec 2024 |
|
| Morgan Stanley | 44k | $42k | -98% | Dec 2024 |
|
| Barclays | 36k | $34k | 0% | Dec 2024 |
|
Who sold out of Revance Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Sep 2024 | 3.5M | $3.0M |
| Citigroup | Sep 2024 | 3.5M | $3.0M |
| Point72 Asset Management | Sep 2024 | 2.0M | $1.7M |
| Brevan Howard Capital Management | Sep 2024 | 2.0M | $1.7M |
| Verition Fund Management | Sep 2024 | 678k | $580k |